Health tech deals

  • Aisel Health secures €1.7 million pre-seed

    Aisel Health has raised €1.7m to expand its clinical and engineering team and support its entry into the UK market. The Copenhagen-based health tech company is developing an operating system for psychiatry designed to reduce administrative work for clinicians by bringing together patient histories, interview recordings, existing documentation and patient accounts. Founded in 2024 by [...]

  • Radar Healthcare acquires Cemplicity to expand patient experience capabilities

    Radar Healthcare has acquired Cemplicity, expanding its patient experience and patient-reported outcomes capabilities. The acquisition brings together two healthcare technology businesses focused on safer care, better experiences, better outcomes and measurable improvement. Radar Healthcare supports health and care organisations with quality, risk, compliance, incident, audit and action management analytics, as well as patient information and [...]

  • Glasgow biopharma Mironid raises €39.9 million Series B

    Glasgow biopharma firm Mironid has closed a €39.9m Series B round to advance its lead drug candidate for the inherited kidney disease ADPKD. The funding will support clinical development of the company’s first-in-class LoAc small molecule candidate for autosomal dominant polycystic kidney disease (ADPKD). ADPKD is an inherited condition, caused predominantly by mutations in the [...]

  • Assured raises US$19M Series A

    Assured has raised US$19m in Series A funding to expand its provider platform and automate more healthcare administration. The New York-based company automates clinician credentialing and payer enrolment and works with more than 100 healthcare organisations, including hospital systems, digital health providers and physician groups. Assured claims its software helps clinicians join insurer networks around [...]

  • AI doctor startup Doctronic acquires Summer Health

    Doctronic has acquired Summer Health as the AI doctor startup expands beyond adult primary care into text-based paediatric care. The financial terms of the acquisition were not disclosed. Doctronic is an AI-based primary care provider that says it has supported 30m health encounters since launching two years ago. The company offers a free [...]

  • Zero Candida market set to reach over US$2 billion by 2030 – report

    A market analysis made by Moore Financial Consulting estimates the global market for Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the "Company" or "ZCT"), a FemTech medical device company advancing next-generation solutions for women’s health, will reach over USD 2 billion by 2030, with a compound annual growth rate of 5.25 per [...]

  • Six-month programme to give health tech startups direct NHS access

    A six-month health tech accelerator offering direct NHS access has opened applications for its final 2026 cohort in West Yorkshire. Propel Healthtech West Yorkshire is inviting early-stage and scaling businesses with technologies for the NHS and wider healthcare system to apply. The fully funded programme is delivered by Health Innovation Yorkshire & Humber in partnership [...]

  • Venture firm Evidenced closes US$24m Fund I

    Venture firm Evidenced has closed Fund I at US$24m. Investors include the Rockefeller Foundation, RockCreek Group and Colibri Equity Ventures, alongside individual limited partners from government, healthcare delivery, technology and the payer ecosystem. Limited partners are investors in a venture fund, while the payer ecosystem refers to organisations that pay for healthcare, including insurers and [...]

  • Daniel Ek’s Neko Health raises US$700m for preventative health tech

    Neko Health has raised US$700m to fund its first US expansion, new clinics and further development of its preventative health tech. The Series C round follows a US$260m Series B in January 2025. Founded by Spotify’s Daniel Ek and Hjalmar Nilsonne, Neko Health offers a 60-minute scan designed to help people understand and act on [...]

  • Withings acquires Biosency and enters respiratory monitoring space

    Withings has acquired Biosency, expanding its remote monitoring capabilities for patients with respiratory insufficiency. The connected health company said the deal supports its ambition to build an independent European business serving changing healthcare systems. Founded in Rennes in 2017, Biosency has developed a modular remote monitoring system for patients with respiratory insufficiency and their caregivers. [...]